A CLINICAL TRIAL O STUDY THE EFFECTIVENESS AND SAFETY OF FERRIC CARBOXYMALTOSE V/S IRON SUCROSE FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN POST NATAL WOMEN

A HOSPITAL BASED PROSPECTIVE COMPARATIVE STUDY OF EFFECTIVENESS AND SAFETY OF FERRIC CARBOXYMALTOSE V/S IRON SUCROSE FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN POST NATAL WOMEN

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/052135

Enrollment

220

Registered

2023-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: Treatment of iron deficiency anaemia in post natal women: Effectiveness of two drugs (iron sucrose and ferric carboxymaltose) are given intravenously to post natal women for the treatme

Eligibility

Inclusion criteria

Inclusion criteria: Post natal women with Hb >=7gm% to <11gm%

Exclusion criteria

Exclusion criteria: 1. Post natal women with Hb 11gm% 2. Patient not willing to give consent 3. Patient with known hypersensitivity to parenteral iron therapy 4. Patient with known liver disease, kidney disease, heart disease, HIV or thalassemia

Design outcomes

Primary

Measure	Time frame
Rise in Hemoglobin and serum Ferritin level of patientsTimepoint: 6weeks	—

Secondary

Measure	Time frame
Rise of Hemoglobin and iron profiles in anaemiaTimepoint: 7weeks-8weeks	—

Countries

India

Contacts

Public ContactJabin Sultana Laskar

Tezpur Medical College and Hospital

gitanjali.dk@gmail.com9864094184

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026